Clinical trial

Study of COPD Subgroups and Biomarkers

NCT01969344

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2010-11-01

PhaseN/A

Study timeline

Study start (unknown)2010-11-01Date precision: month

Registry last updated2025-11-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPDunresolved

Chronic Obstructive Pulmonary Diseaseunresolved

Chronic Bronchitisunresolved

Emphysemaunresolved

Interventions

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

COPD Foundationcollaborator

Columbia Universitycollaborator

Johns Hopkins Universitycollaborator

National Jewish Healthcollaborator

Temple Universitycollaborator

University of Alabama at Birminghamcollaborator

University of California, Los Angelescollaborator

University of California, San Franciscocollaborator

University of Illinois at Chicagocollaborator

University of Iowacollaborator

University of Michigancollaborator

University of Utahcollaborator

Wake Forest Universitycollaborator

Mapped research locations

New YorkNew York, United States2 ChicagoIllinois, United States1 Los AngelesCalifornia, United States1 PhiladelphiaPennsylvania, United States1 BaltimoreMaryland, United States1 San FranciscoCalifornia, United States1 BirminghamAlabama, United States1 DenverColorado, United States1 Ann ArborMichigan, United States1 Salt Lake CityUtah, United States1 Winston-SalemNorth Carolina, United States1 ScottsdaleArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01969344 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.